Atrial Fibrillation
文献摘要
Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with substantial morbidity, including stroke, heart failure, hospitalization, and reduced quality of life.[PMID: 38043043] Atrial fibrillation results from disorganized atrial electrical activity that produces an irregular ventricular rhythm and may cause a rapid ventricular response. The pulmonary veins are important sources of atrial fibrillation triggers, particularly in paroxysmal disease, while progressive electrical and structural remodeling can promote persistence and progression of the arrhythmia. Atrial fibrillation is promoted by a complex interaction of electrical, structural, and clinical factors. Hypertension, obesity, diabetes mellitus, heart failure, coronary artery disease, sleep-disordered breathing, alcohol consumption, and advancing age are among the important risk factors associated with its development and progression. Loss of effective atrial contraction and irregular ventricular activation can impair cardiac function, while blood stasis, particularly in the left atrial appendage, promotes thrombus formation and increases the risk of systemic thromboembolism and ischemic stroke. For this reason, evaluation and management of atrial fibrillation require assessment of the arrhythmia itself as well as associated cardiovascular disease, thromboembolic risk, modifiable risk factors, symptoms, and patient-specific treatment goals. Current management emphasizes comprehensive risk-factor modification, stroke prevention, and individualized rate- or rhythm-control strategies, with catheter ablation increasingly used earlier in selected patients.